12/15
09:18 am
anix
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic [Yahoo! Finance]
Medium
Report
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic [Yahoo! Finance]
12/15
08:45 am
anix
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
Medium
Report
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
12/12
08:06 am
anix
Anixa Biosciences (NASDAQ:ANIX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
High
Report
Anixa Biosciences (NASDAQ:ANIX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
12/11
06:27 pm
anix
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants [Yahoo! Finance]
High
Report
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants [Yahoo! Finance]
12/11
06:02 pm
anix
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
High
Report
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
12/10
09:00 am
anix
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
Low
Report
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
11/17
09:22 am
anix
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization [Yahoo! Finance]
Low
Report
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization [Yahoo! Finance]
11/17
08:15 am
anix
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
Low
Report
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
11/12
01:24 pm
anix
Anixa Biosciences (NASDAQ:ANIX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Anixa Biosciences (NASDAQ:ANIX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
11:51 am
anix
Anixa Biosciences: Hard To Justify The Market's Optimism With An Upcoming Phase 1 Readout [Seeking Alpha]
Low
Report
Anixa Biosciences: Hard To Justify The Market's Optimism With An Upcoming Phase 1 Readout [Seeking Alpha]
11/12
09:00 am
anix
Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
Medium
Report
Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
11/10
10:58 am
anix
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025 [Yahoo! Finance]
Low
Report
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025 [Yahoo! Finance]
11/10
10:30 am
anix
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
Low
Report
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
11/7
01:12 am
anix
Anixa Biosciences (NASDAQ:ANIX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Anixa Biosciences (NASDAQ:ANIX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/5
08:55 am
anix
Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
Low
Report
Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
10/23
08:45 am
anix
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Low
Report
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
10/22
06:56 am
anix
Anixa Biosciences (NASDAQ:ANIX) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Anixa Biosciences (NASDAQ:ANIX) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
10/20
08:25 am
anix
Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Medium
Report
Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
10/8
11:01 am
anix
Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034
Medium
Report
Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034
10/8
10:58 am
anix
Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034
Medium
Report
Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034
10/7
11:05 am
anix
Anixa Biosciences (NASDAQ:ANIX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
High
Report
Anixa Biosciences (NASDAQ:ANIX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
10/7
08:39 am
anix
Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial [Yahoo! Finance]
High
Report
Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial [Yahoo! Finance]
10/7
08:30 am
anix
Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
High
Report
Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial